Welcome to LookChem.com Sign In|Join Free
  • or
5-Boc-1-Phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine is a chemical compound belonging to the tetrahydropyrazolo[4,3-c]pyridine class, known for its biological activity. 5-Boc-1-Phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine features a Boc (tert-butyloxycarbonyl) protecting group and a phenyl group, which may contribute to its potential use as a building block in the synthesis of other organic compounds or as a precursor in the development of new pharmaceuticals. Its structure suggests possible pharmacological effects, and further research is needed to explore its properties and applications.

1075729-08-6

Post Buying Request

1075729-08-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1075729-08-6 Usage

Uses

Used in Pharmaceutical Industry:
5-Boc-1-Phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine is used as a building block for the synthesis of other organic compounds due to its Boc protecting group and phenyl group, which can be utilized in the development of new drugs with potential therapeutic effects.
Used in Chemical Synthesis:
5-Boc-1-Phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine is used as a precursor in the development of new pharmaceuticals, as its structure may possess pharmacological effects that can be further explored and optimized for specific applications in medicine.

Check Digit Verification of cas no

The CAS Registry Mumber 1075729-08-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,5,7,2 and 9 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1075729-08:
(9*1)+(8*0)+(7*7)+(6*5)+(5*7)+(4*2)+(3*9)+(2*0)+(1*8)=166
166 % 10 = 6
So 1075729-08-6 is a valid CAS Registry Number.

1075729-08-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 1-phenyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1075729-08-6 SDS

1075729-08-6Relevant academic research and scientific papers

ANNULATED GLYCOSIDASE INHIBITORS

-

, (2019/03/12)

Compounds of formula (I) wherein A, R, W1, W2, W3, W4, W5, W6, L, Q, Rx and u have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS

-

Page/Page column 13, (2012/10/08)

The disclosure relates to (heterocycle-fused piperidine)-(piperazinyl)-1-alkanone derivatives and (heterocycle-fused pyrrolidine)-(piperazinyI)-1-alkanone derivatives of formula (I): wherein A, W, R2 and n are as defined in the disclosure, to the method o

DIKETO AZOLOPIPERIDINES AND AZOLOPIPERAZINES AS ANTI-HIV AGENTS

-

Page/Page column 96, (2010/01/30)

Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, diketo fused azolopiperidine and azolopiperazine derivatives that possess unique antiviral activity are provided. These compounds are useful the treatment of HIV and AIDS.

HETEROBICYCLIC COMPOUNDS USEFUL AS KINASE INHIBITORS

-

Page/Page column 32, (2008/12/08)

A compound of Formula (I) and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I, and methods of treating conditions associated with the activity of p3

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1075729-08-6